MoneyWorks4Me

Aurobindo Pharma informs about unaudited financial results

10 Feb 2023 Evaluate

Pursuant to Regulation 33(3) (d) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has submitted the Unaudited Financial Results for the Quarter and Nine Months ended on 31st December, 2022 along with Limited Review Report.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..